首页 › 基金 › DME Capital Management, LP › TEVA
DME Capital Management, LP 对 TEVA 的持仓历史
TEVA PHARMACEUTICAL INDS LTD · 医疗保健
DME Capital Management, LP 在 Q3 2026 的 13F 申报中披露持有 TEVA(TEVA PHARMACEUTICAL INDS LTD)1,817,146 股,市值约 US$72.0M,约占其申报组合的 2.03%,在其申报持仓中市值排名第 19 位。 DME Capital Management, LP 最近 11 个申报季度中有 11 个季度披露了 TEVA 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
DME Capital Management, LP 对 TEVA 的持仓演变
DME Capital Management, LP 于 Q1 2024 首次披露 TEVA 持仓:324,850 股(约 US$4.6M)。 该持仓在 Q2 2026 达到峰值 2,886,059 股,市值约 US$97.8M。 在 11 次申报中,DME Capital Management, LP 3 次增持、4 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 1,817,146 股、市值约 US$72.0M,环比减持 -1,068,913 股。。 持仓曾出现大幅变动:Q4 2024 增持约 44% (随后一个季度股价下跌 30%)、Q2 2025 增持约 565% (随后一个季度股价上涨 21%)、Q3 2026 减持约 37% (随后一个季度股价上涨 8%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 324.85K | $4.58M | 新进 |
| Q2 2024 | 324.85K | $5.28M | 持有 |
| Q3 2024 | 324.85K | $5.85M | 持有 |
| Q4 2024 | 468.55K | $10.33M | 增持 |
| Q1 2025 | 568.20K | $8.73M | 增持 |
| Q2 2025 | 3.78M | $63.33M | 增持 |
| Q3 2025 | 3.78M | $76.33M | 持有 |
| Q4 2025 | 3.06M | $95.46M | 减持 |
| Q1 2026 | 2.91M | $87.67M | 减持 |
| Q2 2026 | 2.89M | $97.78M | 减持 |
| Q3 2026 | 1.82M | $71.96M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TEVA 与 13F 数据
TEVA(TEVA PHARMACEUTICAL INDS LTD)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 TEVA,申报仓位最大的包括:BANK OF MONTREAL /CAN/ (US$4.53B), Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TEVA 的基金
- BANK OF MONTREAL /CAN/ 1.13M 股 · $4.53B · Q3 2026
- Phoenix Financial Ltd. 42.63M 股 · $1.69B · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 42.25M 股 · $1.68B · Q3 2026
- Clal Insurance Enterprises Holdings Ltd 42.01M 股 · $1.67B · Q3 2026
- Migdal Insurance & Financial Holdings Ltd. 39.42M 股 · $1.56B · Q3 2026
- Harel Insurance Investments & Financial Services Ltd. 34.66M 股 · $1.37B · Q3 2026
- Lingotto Investment Management LLP 17.53M 股 · $694.38M · Q3 2026
- Altshuler Shaham Ltd 12.43M 股 · $499.58M · Q3 2026
- Rubric Capital Management LP 11.57M 股 · $458.37M · Q3 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 7.57M 股 · $299.65M · Q3 2026
- Y.D. More Investments Ltd 6.92M 股 · $277.37M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 6.12M 股 · $242.31M · Q3 2026
更多关于 DME Capital Management, LP
常见问题
How long has DME Capital Management, LP held TEVA?
DME Capital Management, LP has disclosed TEVA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is DME Capital Management, LP's current position in TEVA?
As of Q3 2026, DME Capital Management, LP holds 1.82M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $71.96M, representing 2.03% of its reported portfolio and ranking #19.
Has DME Capital Management, LP been buying or selling TEVA?
In the latest 13F filing (Q3 2026), DME Capital Management, LP reduced its position in TEVA. The position peaked in Q2 2026 at 2.89M shares.
Which other funds hold TEVA?
Other major institutional holders of TEVA include BANK OF MONTREAL /CAN/, Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.